Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GanMaoKangNing Granules for Epidemic Influenza
NCT02989012Phase 2Unknown
- Sponsor
- Zhen-Ao Bio-Tech
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of Ganmao Kangning Granules in influenza (2 arms), sponsored by Zhen-Ao Bio-Tech. Primary endpoint: Flu recovery time at 6 days. Status: unknown.
02
Drugs
Ganmao Kangning Granules
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02989012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02989012.